ACYLANID Drug Patent Profile
✉ Email this page to a colleague
When do Acylanid patents expire, and what generic alternatives are available?
Acylanid is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ACYLANID is acetyldigitoxin. There is one drug master file entry for this compound. Additional details are available on the acetyldigitoxin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACYLANID?
- What are the global sales for ACYLANID?
- What is Average Wholesale Price for ACYLANID?
Summary for ACYLANID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 457 |
| DailyMed Link: | ACYLANID at DailyMed |
US Patents and Regulatory Information for ACYLANID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ACYLANID | acetyldigitoxin | TABLET;ORAL | 009436-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
